Relationship of urinary pseudouridine and l-methyladenosine to activity of leukemia and lymphoma
Authors:
- 31 March 1992
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 206 (3) , 181-189
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibodyClinica Chimica Acta, 1989
- Suppressive effect of 1-methyladenosine on the generation of chemiluminescence by mouse peritoneal macrophages stimulated with opsonized zymosan.The Tohoku Journal of Experimental Medicine, 1989
- Preparation of a Monoclonal Antibody Specific for 1‐Methyladenosine and Its Application for the Detection of Elevated Levels of 1‐Methyladenosine in Urines from Cancer PatientsJapanese Journal of Cancer Research, 1988
- TRANSFER RNA MODIFICATIONAnnual Review of Biochemistry, 1987
- Urinary excretion of pseudouridine in patients with hepatocellular carcinomaCancer, 1986
- Urinary pseudouridine as a tumor marker in patients with small cell lung cancerClinica Chimica Acta, 1986
- Low Molecular Weight Immunosuppressive Factors Found in Elevated Amounts in Cancer Ascitic Fluids of Mice 2. 1-Methyladenosine Isolated from Cancer Ascitic Fluids Enhances Listeria Infection in MiceImmunopharmacology and Immunotoxicology, 1986
- Urinary nucleic acid breakdown products as markers for trophoblastic diseasesAmerican Journal of Obstetrics and Gynecology, 1983
- tRNA breakdown products as markers for cancerCancer, 1979
- Atypical Transfer RNA's And Their Origin In Neoplastic Cells1972